Markets:

Overview

News

Currencies

International

Treasuries

HEALTHCARE (NY:XLV)

167.10 -1.32 (-0.78%)

Streaming Delayed Price Updated: 10:42 AM EDT, Oct 1, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about HEALTHCARE

< Previous 1 2

...

28 29 30 31 32 33 34 35 36

...

44 45 Next >

Regeneron Beats Q1 Views, But Stock Drops On Weak Eye Med Sales

May 05, 2023

Regeneron reported better-than-expected Q1 earnings and revenue, but its Eylea sales fell, losing ground to Roche's newly launched Vabysmo.

Via MarketBeat

6 Best Healthcare Stocks to Buy Right Now

April 25, 2023

Whether you invest in healthcare stocks for pharmaceuticals, medical devices or health insurance, the opportunities are limitless. Learn more with MarketBeat.

Via MarketBeat

Topics Economy Intellectual Property

Healthcare Sector Update: MedTech Trending Up ↗

April 20, 2023

Earnings from major device companies and large-cap biopharma over the next two weeks will help us ascertain risks for the market.

Via Talk Markets

Healthcare Innovation Drives Medical Device Makers To New Highs

April 17, 2023

Medical products makers Stryker and Boston Scientific are rallying to all-time highs, while sector peer DexCom is forming a constructive base.

Via MarketBeat

Tuesday Talk: Eggs Still In The Basket ↗

April 11, 2023

Investors returned to the market Monday, after the Good Friday trading holiday, with most of their eggs still intact. The early Spring rally seems to be holding as the market prepares for Q1 banking...

Via Talk Markets

April Is Busting Out For Healthcare And Biotech ↗

April 10, 2023

Last week was a good week for healthcare stocks and most large cap biopharmaceutical stocks resumed an upward trend.

Via Talk Markets

Weekly Market Pulse: History Lessons ↗

April 10, 2023

Studying the past doesn’t somehow allow us to predict the future. But it does tell us that there is a range of potential outcomes and we should be reluctant to make big changes to our portfolios based...

Via Talk Markets

GILD - Chart Of The Week ↗

April 05, 2023

The daily chart looks pretty strong right now. The stock is trying to break through the resistance line that started around the beginning of December.

Via Talk Markets

Recession Playbook In Action: Cooling Labor Market Triggers Rally In Treasuries, Gold; Stocks Decline ↗

April 04, 2023

Recent economic data has prompted investors to hedge against the rising likelihood of a recession. In February 2023, there were 9.9 million job openings, which was the lowest level since May 2021 and...

Via Benzinga

Large Cap Biopharmaceuticals Q1 2023: In This Bullish Run Biotech Lags ↗

April 03, 2023

It was very difficult to make money in Q1 trading healthcare or biotech ETFs because of the sharp rally in other sectors. Nonetheless, there were two big winners.

Via Talk Markets

Financials And Tech Continue To Split: Your Sector Trade Ideas For The Week Ahead ↗

March 28, 2023

Current trade opportunities for Financials and Tech along with other sectors setting up trade logic.

Via Talk Markets

Energy & Financials Lead, But The Flight To Quality Has Begun ↗

March 27, 2023

It's easy to get suckered into thinking the crisis is over and buy the most oversold stocks. For financials, this comes with significant risk as the

Via Talk Markets

Can Healthcare Stocks Survive Macro Headwinds? ↗

March 27, 2023

Healthcare stocks are supposed to be defensive plays in a choppy market. However, over the past 18 months, the XLV is flat and down 6% over one year.

Via Talk Markets

Sector Performance Experiences A Historical Divergence ↗

March 24, 2023

The first quarter of 2023 is coming to a close next week, and checking in on year-to-date performance, there has been a big divergence between the winners and losers.

Via Talk Markets

Small Cap Biotechs Slammed By SVB Collapse ↗

March 13, 2023

Nothing like a banking crisis to start off a weekend. But maybe by the end of this upcoming week of turmoil we'll worry less about inflation.

Via Talk Markets

FDA Seeks 10% Increase In Biden's FY 2024 Budget, Proposes Enhancing Regulatory Authorities ↗

March 10, 2023

Via Benzinga

U.S. Weekly Fund-Flows Insight Report: Investors Embrace Both Fixed Income And Equity ETFs ↗

March 09, 2023

As investors appeared to ignore rising Treasury yields, stocks generally managed to remain on the plus-side for the fund-flows week.

Via Talk Markets

Covis Pharma To Withdraw Only FDA-Approved Treatment To Prevent Preterm Births ↗

March 08, 2023

Via Benzinga

Health Care ETFs Have Lost In The Last Month - These Top Pharma Stocks Are The Reason ↗

March 07, 2023

Via Benzinga

A Market And Economy Exceeding Expectations ↗

March 06, 2023

Knowing the economy and investment market are not one and the same, and can function out of sync at times, possibly the current environment is such that they are actually in sync.

Via Talk Markets

S&P 500 2022 Q4 Earnings Review: Swing And A Miss ↗

February 21, 2023

In many ways, this quarter behaved in a way that met the expectations of most market commentators, earnings are too high, an erosion of pricing power since the pandemic, and that higher costs will bite...

Via Talk Markets

Identifying The Dimension Where Deterministic Chaos Is Alive In The Stock Market ↗

February 21, 2023

We have estimated approximate entropy for the S&P 500 and its SPDR ETF and we have noticed that all of them have non-linear dependence patterns for the dimension of 3 or 4 days.

Via Talk Markets

Tuesday Talk: My Sweet CPI ↗

February 14, 2023

The street is hoping for sweet January CPI data today and that anticipation pushed stocks higher on Monday.

Via Talk Markets

Large-Cap Biopharmaceuticals: Bearish Sentiment Curbs Buyers ↗

February 13, 2023

Large cap biopharma stocks are off their highs despite reasonable valuations plus dividends.

Via Talk Markets

A Bull Market Is Coming. Should You Return to Growth Stocks? ↗

February 11, 2023

Growth stocks could be among the first to rally in a bull market.

Via The Motley Fool

This Low-Risk ETF Can Turn $39,000 Into $1 Million in 25 Years ↗

February 02, 2023

Funneling money into this fund can drastically simplify your investing strategy.

Via The Motley Fool

10 Names For Half The Move ↗

February 01, 2023

In January, sectors like Tech, Communication Services, and Consumer Discretionary saw massive outperformance following the opposite playing out throughout 2022.

Via Talk Markets

Sector Divergence, Earnings Stats ↗

January 31, 2023

Over these last few weeks, as the broad market has rallied, we've definitely seen some sector divergence.

Via Talk Markets

Sector Shift Stalls Healthcare Stocks But Biotech Shows Gains In January ↗

January 30, 2023

Biotech stocks are off to a great start in 2023 with the IBB up 4.5% and the XBI up 7.7%.

Via Talk Markets

Healthcare Sector Is Lagging As We Enter 2022 Earnings Season ↗

January 23, 2023

The healthcare sector is perceived as defensive but in 2023 there is more investor appetite for risk based on the QQQ comeback and the XBI strength.

Via Talk Markets

< Previous 1 2

...

28 29 30 31 32 33 34 35 36

...

44 45 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.